Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

Hospital Universitario Virgen de la Arrixaca

Davlat:
ES
ROR:
https://ror.org/058thx797
2
h-indeks
8
Iqtiboslar
11
Asarlar
20
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0358100134520092012201620202024202520262009: Nashrlar 1, Iqtiboslar 02012: Nashrlar 1, Iqtiboslar 02016: Nashrlar 0, Iqtiboslar 12020: Nashrlar 1, Iqtiboslar 02024: Nashrlar 0, Iqtiboslar 42025: Nashrlar 2, Iqtiboslar 02026: Nashrlar 6, Iqtiboslar 3

Iqtibos tarixi

0134520092012201620202024202520262009: Iqtiboslar 02012: Iqtiboslar 02016: Iqtiboslar 12020: Iqtiboslar 02024: Iqtiboslar 42025: Iqtiboslar 02026: Iqtiboslar 3

Nashr tarixi

03581020092012201620202024202520262009: Nashrlar 12012: Nashrlar 12016: Nashrlar 02020: Nashrlar 12024: Nashrlar 02025: Nashrlar 22026: Nashrlar 6

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01220092012201620202024202520262009: h-indeks 02012: h-indeks 02016: h-indeks 12020: h-indeks 12024: h-indeks 22025: h-indeks 22026: h-indeks 2

Eng koʻp iqtibos qilingan asarlar

  1. Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?—a systematic review and meta-analysis20250 iqtibos
  2. Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis20260 iqtibos
  3. Management of inguinal and femoral hernias in women: meta analysis of current practices and review of international guidelines20260 iqtibos
  4. Outcomes following 2-stage hepatectomy: Systematic review and meta-analysis exploring liver regeneration strategies20260 iqtibos
  5. ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis20260 iqtibos
  6. Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis20260 iqtibos
  7. Benefit of Adjuvant Chemotherapy for Resected Pancreatic Cancer Following Neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: A Multinational Analysis20260 iqtibos